Novel irreversible small molecule inhibitors of replication protein A display single-agent activity and synergize with cisplatin
about
MutS homologue hMSH5: role in cisplatin-induced DNA damage responseDNA repair targeted therapy: The past or future of cancer treatment?Protein Recognition in Drug-Induced DNA Alkylation: When the Moonlight Protein GAPDH Meets S23906-1/DNA Minor Groove AdductsChemotherapeutic compounds targeting the DNA double-strand break repair pathways: the good, the bad, and the promisingDrugging the Cancers Addicted to DNA Repair.Targeting DNA repair pathways for cancer treatment: what's new?Translational regulation of RPA2 via internal ribosomal entry site and by eIF3aChemical inhibitor targeting the replication protein A-DNA interaction increases the efficacy of Pt-based chemotherapy in lung and ovarian cancerHuman single-stranded DNA binding proteins: guardians of genome stability.Replication Protein A (RPA) deficiency activates the Fanconi anemia DNA repair pathway.Ligand-independent and tissue-selective androgen receptor inhibition by pyrvinium.Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells.Small-molecule inhibitors of DNA damage-repair pathways: an approach to overcome tumor resistance to alkylating anticancer drugs.Targeting homologous recombination-mediated DNA repair in cancer.Molecular Pathways: Overcoming Radiation Resistance by Targeting DNA Damage Response Pathways.Molecular approaches to potentiate cisplatin responsiveness in carcinoma therapeutics.Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies.DNA repair pathways and cisplatin resistance: an intimate relationship
P2860
Q24306821-D684AC30-7F4D-4055-A755-0FCC3E2F2035Q26768679-F2D071BF-B98E-4C38-BEE7-6157DE9172A7Q26778143-A3AEE548-157F-4420-AA87-5CD637C5E49CQ26863501-C1BC4B61-9A96-4BE7-AB37-5E6776B30DFFQ33702497-7D0F9050-21F9-4F10-8402-956FED69E7CCQ34015040-5F1E5472-DF1D-45F2-838F-2801C22EDB4AQ34580793-C051CB74-5005-48AA-A4DB-E34C4AFA405EQ34849073-D6AF4E76-69F1-457C-B718-A683F7F45D32Q36027589-D757D965-1A05-4D24-BCCC-20BC5CB06F10Q36072502-7A355EDE-05DE-4D12-BE28-7BEE97A77A77Q37656304-B7E2E4B3-9190-4490-8BD6-0D4FE7AD17B1Q37688903-177ADA51-AFD1-49E1-8CFC-374EBF3FE0C5Q38019607-1ED50A7C-7F9B-453E-8E9F-7B06709A470EQ38184667-D85E61B9-5998-4109-B8EB-6E6086A5D6EAQ38541699-048A939E-33A7-4D11-BABB-FD8D3F4E7630Q39433258-80A79759-A1E2-4C4B-9CA8-FE6B82215FE7Q55100687-1B5E865F-6326-4157-974D-9774D34E7A53Q58699219-79B01E81-5F01-43B5-B9D0-BCE617598844
P2860
Novel irreversible small molecule inhibitors of replication protein A display single-agent activity and synergize with cisplatin
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Novel irreversible small molec ...... y and synergize with cisplatin
@ast
Novel irreversible small molec ...... y and synergize with cisplatin
@en
type
label
Novel irreversible small molec ...... y and synergize with cisplatin
@ast
Novel irreversible small molec ...... y and synergize with cisplatin
@en
prefLabel
Novel irreversible small molec ...... y and synergize with cisplatin
@ast
Novel irreversible small molec ...... y and synergize with cisplatin
@en
P2093
P2860
P1476
Novel irreversible small molec ...... y and synergize with cisplatin
@en
P2093
Diane Bodenmiller
John J Turchi
Richard W Fitch
Shadia I Jalal
Tracy M Neher
P2860
P304
P356
10.1158/1535-7163.MCT-11-0303
P577
2011-08-16T00:00:00Z